Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer
出版年份 2020 全文链接
标题
Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer
作者
关键词
-
出版物
Cancer Cell International
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-11-24
DOI
10.1186/s12935-020-01660-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
- (2020) Cord Naujokat et al. CURRENT MEDICINAL CHEMISTRY
- Sodium butyrate inhibits migration and induces AMPK‐mTOR pathway‐dependent autophagy and ROS‐mediated apoptosis via the miR‐139‐5p/Bmi‐1 axis in human bladder cancer cells
- (2020) Feifan Wang et al. FASEB JOURNAL
- Antitumor Effects of Curcumin and Glycyrrhetinic Acid-Modified Curcumin-Loaded Cationic Liposome by Intratumoral Administration
- (2020) Mingxiang Chang et al. Evidence-based Complementary and Alternative Medicine
- Curcumin—A Viable Agent for Better Bladder Cancer Treatment
- (2020) Jochen Rutz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosis
- (2020) Aziza A. M. El-Shafey et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications
- (2020) Javad Sharifi-Rad et al. Frontiers in Pharmacology
- Direct Conjugation of Resveratrol on Hydrophilic Gold Nanoparticles: Structural and Cytotoxic Studies for Biomedical Applications
- (2020) Iole Venditti et al. Nanomaterials
- Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer
- (2020) Srikala S. Sridhar et al. JAMA Oncology
- Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer
- (2019) Xiaoxia Jin et al. Cancer Medicine
- PIK3CA in cancer: The past 30 years
- (2019) Rand Arafeh et al. SEMINARS IN CANCER BIOLOGY
- Health benefits of resveratrol: Evidence from clinical studies
- (2019) Akhand Pratap Singh et al. MEDICINAL RESEARCH REVIEWS
- Identification of novel targets in non-muscle invasive bladder cancer: A systems biology approach.
- (2019) Robin Osterhout et al. JOURNAL OF CLINICAL ONCOLOGY
- MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling
- (2019) Wei Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer
- (2019) Li Zhang et al. DISEASE MARKERS
- Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
- (2019) Anthony D. Saleh et al. CLINICAL CANCER RESEARCH
- Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status
- (2019) Tamires Cunha Almeida et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer
- (2019) Wei Jiang et al. SEMINARS IN CANCER BIOLOGY
- Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress
- (2019) Sara Rodríguez-Enríquez et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- mTOR Signalling in Head and Neck Cancer: Heads Up
- (2019) Tan et al. Cells
- Is curcumin bioavailability a problem in humans: lessons from clinical trials
- (2019) Ajaikumar B. Kunnumakkara et al. Expert Opinion on Drug Metabolism & Toxicology
- MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53
- (2019) Ran Xu et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models
- (2019) Anna Hernández-Prat et al. MOLECULAR CANCER RESEARCH
- AMPK‐mTOR‐ULK1 axis activation‐dependent autophagy promotes hydroxycamptothecin‐induced apoptosis in human bladder cancer cells
- (2019) Feifan Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Malva species: Insights on its chemical composition towards pharmacological applications
- (2019) Javad Sharifi‐Rad et al. PHYTOTHERAPY RESEARCH
- MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway
- (2019) Shuo Liu et al. Human Cell
- Berberis Plants—Drifting from Farm to Food Applications, Phytotherapy, and Phytopharmacology
- (2019) Bahare Salehi et al. Foods
- Role of resveratrol in modulating microRNAs in human diseases: From cancer to inflammatory disorder
- (2019) Atefeh Amiri et al. CURRENT MEDICINAL CHEMISTRY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era
- (2018) Sandy T. Liu et al. Clinical Genitourinary Cancer
- Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers
- (2018) Ammad Farooqi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Down-regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer
- (2018) Qiongli Su et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression
- (2018) Chengdi Yang et al. Molecular Cancer
- SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival
- (2018) J. Y. Liu et al. ONCOGENE
- Resveratrol Mediated Cancer Cell Apoptosis, and Modulation of Multidrug Resistance Proteins and Metabolic Enzymes
- (2018) Mahmoud Zaki El-Readi et al. PHYTOMEDICINE
- Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool
- (2018) David D′Andrea et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells
- (2018) Te-Fu Tsai et al. OncoTargets and Therapy
- The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells
- (2018) Robert Kleszcz et al. Advances in Clinical and Experimental Medicine
- Curcumin Suppresses microRNA-7641-Mediated Regulation of p16 Expression in Bladder Cancer
- (2018) Kai Wang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Downregulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis
- (2018) Ting Tao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection
- (2018) Martin C. S. Wong et al. Scientific Reports
- MiR-99a-5p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival
- (2018) Yan Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Glycoprotein-130 expression is associated with aggressive bladder cancer and is a potential therapeutic target
- (2018) Darryl T. Martin et al. MOLECULAR CANCER THERAPEUTICS
- mTOR as a central hub of nutrient signalling and cell growth
- (2018) Joungmok Kim et al. NATURE CELL BIOLOGY
- Non-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathway
- (2018) Yan Guo et al. Cancer Management and Research
- Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets
- (2017) Eugene J. Pietzak et al. EUROPEAN UROLOGY
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Cancer-associated fibroblasts secreted exosomal miR-146a promotes bladder cancer progression
- (2017) J. Zhuang et al. EUROPEAN UROLOGY SUPPLEMENTS
- Long-Lived Epidermal Cancer-Initiating Cells
- (2017) Marina Youssef et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA: A novel target of curcumin in cancer therapy
- (2017) Hamed Mirzaei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway
- (2017) Binqiang Tian et al. JOURNAL OF DRUG TARGETING
- Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells
- (2017) Shanshan Wang et al. Molecular Medicine Reports
- Natural products modulating the hERG channel: heartaches and hope
- (2017) Jadel M. Kratz et al. NATURAL PRODUCT REPORTS
- Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy
- (2017) Yumeng Wei et al. ONCOLOGY REPORTS
- Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile
- (2017) Yang Yang et al. Oncotarget
- Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?
- (2016) Ammad Ahmad Farooqi et al. Chemical Biology & Drug Design
- miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells
- (2016) Li-Ping Zeng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer
- (2016) Anya Alayev et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis
- (2016) Jian Xiao et al. OncoTargets and Therapy
- Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway
- (2016) Sai-Qi Wang et al. Oncotarget
- Cisplatin and Paclitaxel Alter the Expression Pattern of miR-143/145 and miR-183/96/182 Clusters in T24 Bladder Cancer Cells
- (2015) Emmanuel I. Papadopoulos et al. CTS-Clinical and Translational Science
- Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP
- (2015) S J H Ricoult et al. ONCOGENE
- Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway
- (2015) XIAOPING JING et al. ONCOLOGY REPORTS
- A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination
- (2015) Channing J. Paller et al. PROSTATE
- Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men
- (2015) Thomas Nordstrøm Kjaer et al. PROSTATE
- MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1
- (2015) Yidong Cheng et al. TUMOR BIOLOGY
- Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer
- (2015) Swati Dhar et al. Oncotarget
- MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9
- (2014) A Y Jia et al. BRITISH JOURNAL OF CANCER
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Resveratrol induces apoptosis of bladder cancer cells via miR-21 regulation of the Akt/Bcl-2 signaling pathway
- (2014) CHENXI ZHOU et al. Molecular Medicine Reports
- Short-Term Resveratrol Exposure Causes In Vitro and In Vivo Growth Inhibition and Apoptosis of Bladder Cancer Cells
- (2014) Mo-Li Wu et al. PLoS One
- Resveratrol encapsulation: Designing delivery systems to overcome solubility, stability and bioavailability issues
- (2014) Gabriel Davidov-Pardo et al. TRENDS IN FOOD SCIENCE & TECHNOLOGY
- Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
- (2014) FANG HUANG et al. Experimental and Therapeutic Medicine
- Targeting mTOR: Evaluating the Therapeutic Potential of Resveratrol for Cancer Treatment
- (2013) Yan Wu et al. Anti-Cancer Agents in Medicinal Chemistry
- MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
- (2013) Liu Hong et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Regulatory effects of resveratrol on antioxidant enzymes: A mechanism of growth inhibition and apoptosis induction in cancer cells
- (2013) Md. Asaduzzaman Khan et al. MOLECULES AND CELLS
- Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy
- (2013) José Díaz-Chávez et al. PLoS One
- Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder
- (2013) Heejeong Lee et al. VIRCHOWS ARCHIV
- Expression of glucose transporters in cancers
- (2012) Leszek Szablewski BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
- (2012) Rakesh Popat et al. BRITISH JOURNAL OF HAEMATOLOGY
- Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells
- (2012) Xi Lin et al. INTERNATIONAL JOURNAL OF UROLOGY
- Dose-dependent effect of Resveratrol on bladder cancer cells: Chemoprevention and oxidative stress
- (2012) Bianca Stocco et al. MATURITAS
- miRNA-100 Inhibits Human Bladder Urothelial Carcinogenesis by Directly Targeting mTOR
- (2012) C. Xu et al. MOLECULAR CANCER THERAPEUTICS
- Side-effects of resveratrol in HepG2 cells: Reduced pten and increased bcl-xl mRNA expression
- (2012) MIN ZHENG et al. Molecular Medicine Reports
- Untapped mutualistic paradigms linking host plant and endophytic fungal production of similar bioactive secondary metabolites
- (2012) Souvik Kusari et al. PHYTOCHEMISTRY
- Inhibition of Fatty-acid Synthase Suppresses P-AKT and Induces Apoptosis in Bladder Cancer
- (2012) Bo Jiang et al. UROLOGY
- Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
- (2012) Anna-Regina Scheffer et al. WORLD JOURNAL OF UROLOGY
- TSC1/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade
- (2011) Xiaojun Zha et al. CANCER LETTERS
- Targeting apoptosis pathways in cancer stem cells
- (2011) Michele Signore et al. CANCER LETTERS
- Curcumin Modulates MicroRNA-203-Mediated Regulation of the Src-Akt Axis in Bladder Cancer
- (2011) S. Saini et al. Cancer Prevention Research
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma
- (2010) Donna E. Hansel et al. AMERICAN JOURNAL OF PATHOLOGY
- Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]
- (2010) P. Albers et al. ANNALS OF ONCOLOGY
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
- (2010) K. R. Patel et al. CANCER RESEARCH
- The mTOR Pathway: A New Target in Cancer Therapy
- (2010) L. Ciuffreda et al. CURRENT CANCER DRUG TARGETS
- Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines
- (2010) Qi-Qi Mao et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
- (2009) Margaret A. Knowles et al. CANCER AND METASTASIS REVIEWS
- Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cellsin vitroand inhibits tumor growthin vivo
- (2009) Yu Bai et al. CANCER SCIENCE
- mTOR and cancer: many loops in one pathway
- (2009) Alejo Efeyan et al. CURRENT OPINION IN CELL BIOLOGY
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression
- (2008) Carolyn L. Buller et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
- (2008) Tsuneo Ikenoue et al. EMBO JOURNAL
- Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells
- (2008) M. Sun et al. MOLECULAR CANCER THERAPEUTICS
- Clinical Value of PTEN in Patients with Superficial Bladder Cancer
- (2008) Kyung Seok Han et al. UROLOGIA INTERNATIONALIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now